New hope for rare Fat-Loss disorder? diabetes drug enters trial
NCT ID NCT07091734
Summary
This study is testing if a medication called Tirzepatide, already used for diabetes, can help adults with a rare condition called partial lipodystrophy. People with this disorder lose fat tissue abnormally, which often leads to poorly controlled diabetes and high blood fats. Researchers want to see if taking Tirzepatide for 24 weeks improves blood sugar control and lowers triglycerides better than not taking it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPODYSTROPHY, PARTIAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.